Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do They Alter Their Decision with Time?

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†

Robert G. Knodell, Kamal G. Ishak, William C. Black et al. · Hepatology · 1981 · 3.6K citations · Full text

Medicine, Pathology, Hepatology +16

Diagnosis, management, and treatment of hepatitis C†

Doris B. Strader, Teresa L. Wright, David L. Thomas et al. · Hepatology · 2004 · 1.7K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B

Michael F. Sorrell, Edward A. Belongia, José Costa et al. · Annals of Internal Medicine · 2009 · 834 citations

Medicine, Infectious Diseases, Clinical Epidemiology +16

Cost-effectiveness analysis.

Ray Robinson · BMJ · 1993 · 820 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-benefit Analysis +15

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C

Thierry Poynard, Vlad Ratziu, Frédéric Charlotte et al. · Journal of Hepatology · 2001 · 750 citations

Medicine, Pathology, Hepatology +13